YM17E

structure given in first source

Also Known As:

1,3-bis((1-cycloheptyl-3-(4-dimethylaminophenyl)ureido)methyl)benzene dihydrochloride; YM 17E

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Diarrhea 01/01/1997 - "When YM17E was administered at the same total dosage but divided into 5 daily administrations, the incidence of diarrhea was significantly reduced while its cholesterol lowering effect became stronger. " 01/01/1997 - "However, YM17E caused secretory diarrhea in beagle dogs at near lipid lowering doses. "